Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ZEAL

Zealand Pharma AS (ZEAL)

Zealand Pharma AS
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ZEAL
일자시간출처헤드라인심볼기업
2022/11/1023:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Nine Months of 2022NASDAQ:ZEALZealand Pharma AS
2022/11/0822:30GlobeNewswire Inc.Zealand Pharma to Participate in Upcoming Investor ConferencesNASDAQ:ZEALZealand Pharma AS
2022/11/0317:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
2022/11/0201:00GlobeNewswire Inc.Zealand Pharma Announces Presentations at The Obesity Society Annual MeetingNASDAQ:ZEALZealand Pharma AS
2022/10/1200:05GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Polar CapitalNASDAQ:ZEALZealand Pharma AS
2022/10/1100:12GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Van Herk InvestmentsNASDAQ:ZEALZealand Pharma AS
2022/10/0715:41GlobeNewswire Inc.Zealand Pharma completes registration of capital increaseNASDAQ:ZEALZealand Pharma AS
2022/10/0505:07GlobeNewswire Inc.Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 millionNASDAQ:ZEALZealand Pharma AS
2022/10/0500:05GlobeNewswire Inc.Zealand Pharma announces directed issue and private placement of approximately 4.5m new sharesNASDAQ:ZEALZealand Pharma AS
2022/10/0105:15TipRanksNeedham Sticks to Their Buy Rating for Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
2022/10/0105:00GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at September 30, 2022NASDAQ:ZEALZealand Pharma AS
2022/09/3020:41TipRanksZealand Pharma’s (NASDAQ:ZEAL) Phase 3 SBS Trial Sees Positive ResultsNASDAQ:ZEALZealand Pharma AS
2022/09/3019:15GlobeNewswire Inc.Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)NASDAQ:ZEALZealand Pharma AS
2022/09/2121:15GlobeNewswire Inc.Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)NASDAQ:ZEALZealand Pharma AS
2022/09/1915:00GlobeNewswire Inc.Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE MeetingNASDAQ:ZEALZealand Pharma AS
2022/09/1419:11TipRanksAnalysts’ Top Healthcare Picks: Zealand Pharma (ZEAL), POINT Biopharma Global (PNT)NASDAQ:ZEALZealand Pharma AS
2022/09/1405:05GlobeNewswire Inc.Zealand Pharma grants warrants to employees in DenmarkNASDAQ:ZEALZealand Pharma AS
2022/09/0905:05GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
2022/09/0800:00GlobeNewswire Inc.Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:ZEALZealand Pharma AS
2022/09/0715:00GlobeNewswire Inc.Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)NASDAQ:ZEALZealand Pharma AS
2022/09/0104:30GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at August 31, 2022NASDAQ:ZEALZealand Pharma AS
2022/08/2417:30GlobeNewswire Inc.Zealand Pharma Appoints Henriette Wennicke as Chief Financial OfficerNASDAQ:ZEALZealand Pharma AS
2022/08/1903:58GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
2022/08/1202:30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Trevena (TRVN), Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
2022/08/1122:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Half of 2022NASDAQ:ZEALZealand Pharma AS
2022/08/0905:30GlobeNewswire Inc.Updated notice to holders of ADSs regarding termination of Deposit AgreementNASDAQ:ZEALZealand Pharma AS
2022/08/0905:05GlobeNewswire Inc.Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select MarketNASDAQ:ZEALZealand Pharma AS
2022/08/0422:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
2022/07/1419:45TipRanksZealand Pharma (ZEAL) Receives a Buy from NeedhamNASDAQ:ZEALZealand Pharma AS
2022/06/3022:44GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at June 30, 2022NASDAQ:ZEALZealand Pharma AS
 검색 관련기사 보기:NASDAQ:ZEAL